Trial
NCT00585221
Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Utah
Collaborators
Schering-Plough
Condition
Gastrointestinal Stromal Tumors
Intervention
Peginterferon-alpha 2b (PegIFNa2b)
Why stopped
PI terminated at the recommendation of DSMC \& IRB
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-10